Our analysis demonstrates that the presence of CLS in breast adipose tissue of postmenopausal patients with breast cancer is associated with increased ratios of estrogens to androgens in breast fat and serum, consistent with data showing that these microscopic inflammatory lesions are related to increased aromatase activity [10–12]. The gene discussed is CYP19A1; the disease is breast cancer.